Skip to content

Evaluation of the Efficacy of Lifespan Integration (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder

Evaluation of the Efficacy of Lifespan Integration Therapy in Patients With Complex Post-Traumatic Stress Disorder

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06535243
Acronym
EVALI
Enrollment
38
Registered
2024-08-02
Start date
2024-04-01
Completion date
2027-04-01
Last updated
2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abuse Domestic, Abuse Neglect, Abuse Physical, Abuse, Sexual, Abuse Verbal, Post-Traumatic Stress Disorder Complex, Psychiatric Disorder

Keywords

Lifespan Integration Therapy, Psychotrauma type II, Abuse, Victims, Complex Post-traumatic Stress Disorder, Psychotherapy

Brief summary

The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD

Interventions

BEHAVIORALLifespan Integration Therapy (LI)

same as above

Sponsors

Centre Hospitalier St Anne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

eligible candidates to be included in this cohort should be * older than 18 yo * French speaking * with a diagnosis of complex PTSD as confirmed by 1/clinical interview with a trained psychiatrist and 2/ scores for the International Trauma Questionnaire (ITQ), clinical tool based on the ICM 11 criteria

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients diagnosed with complex PTSD * French speaking * first time following an LI type of therapy * psychotropic treatment is allowed

Exclusion criteria

* no other parallel psychotherapy is accepted (if the patient underwent recently any other type of psychotherapy, a wash out period of minimum 4 weeks is required ) * no active manic episode at the time of inclusion * no active psychotic episode at the time of inclusion * no chronic psychotic disorder diagnosis * no autistic spectrum disorder diagnosis , * no intellectual deficit

Design outcomes

Primary

MeasureTime frameDescription
change of the scores of International Trauma Questionnairemaximum one yearInternational Trauma Questionnaire measures subscores of simple and complex PTSD, the score is calculated using an algorithm, a minimum score of 8 for the PTSD simple part and of 8 for PTSD complex part is needed in order to diagnose a complex PTSD; the maximum score for simple PTSD is 16, same for complex PTSD.

Secondary

MeasureTime frameDescription
Difficulties in Emotion Regulation Scale (DERS) Scoremaximum one yearthe DERS scale (Gratz and Roemer, 2004) contains 36 Likert Scale questions with scores from 1 to 5; the scale can generate a total score and six underscores (assessing nonacceptance, goals, impulse, awareness, strategies, clarity); in a general population cohort the mean score was of 77.99 (SD= 20.72) for N=260 women and 80.66 (SD= 18.79) for N=97 men

Other

MeasureTime frameDescription
Rosenberg Self - Esteem Scale (RSES) (Rosenberg, 1965)maximum one yearRSES is one of the most widely used measures of global self esteem; it contains 10 questions with answers ranging from 0 (poor) to 3 (excellent); five questions are positively worded and five questions are negatively worded. Sinclair and colleagues, 2010 reported a mean score of 22.62 (SD=5.80) in a general population cohort from the US of N=503 individuals

Countries

France

Contacts

Primary ContactHayat OUATAH
hayat.ouatah@ghu-paris.fr+331 45 65 84 86
Backup ContactNaoual KHALFI
n.khalfi@ghu-paris.fr+33145658486

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026